key: cord-0753617-8u4wonk3
authors: Schrodt, Caroline A; Malenfant, Jason H; Hunter, Jennifer C; Slifka, Kara Jacobs; Campbell, Angela; Stone, Nimalie; Whitehouse, Erin R; Wittry, Beth; Christensen, Bryan; Barnes, John R; Brammer, Lynnette; Hemarajata, Peera; Green, Nicole M; Civen, Rachel; Gounder, Prabhu P; Rao, Agam K
title: Investigation of a Suspect SARS-CoV-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide
date: 2021-05-06
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab372
sha: 263614687835c0b104507deafd4f70150f1dd258
doc_id: 753617
cord_uid: 8u4wonk3

A suspected outbreak of influenza A and SARS-CoV-2 at a long-term care facility in Los Angeles County was months later, determined to not involve influenza. To prevent inadvertent transmission of infections, facilities should use highly specific influenza diagnostics and follow CDC guidelines that specifically address infection control challenges.

The congregate nature of long-term care facilities (LTCFs) and the resident population, comprising older persons with underlying medical conditions, is associated with rapid transmission and poor outcomes when cases of influenza or COVID-19, have been detected [1, 2] . Concordant outbreaks of both have not previously been reported but can very easily occur.

In March 2020, authorities in Los Angeles County (LAC) were preparing for SARS-CoV-2 cases among LTCF residents. Low activity for influenza virus [3] , along with a county-wide shortage of respiratory swabs, prompted public health officials to recommend swabs be reserved for evaluation of SARS-CoV-2 only. Facility staff, unaware of this guidance, continued to evaluate respiratory symptoms with two swabs; those for SARS-CoV-2 were tested at LAC Public Health Laboratory (PHL) and those for influenza were tested at a commercial laboratory.

On April 16, local health authorities were notified of concurrent outbreaks of SARS-CoV-2 and influenza A among Facility A residents. An investigation was launched to determine the extent of the outbreak and an Infection Control and Assessment Response tool was used to understand how infections spread [4] .

A case of COVID-19 was defined as a positive test result for SARS-CoV-2 using the A c c e p t e d M a n u s c r i p t infections among residents, including 21 SARS-CoV-2 only, two influenza A only, one influenza B only, and seven mixed SARS-CoV-2/influenza A infections; 18 (58%) residents were hospitalized and 17 (55%) died, all of whom were positive for SARS-CoV-2 (Table 1) .

To understand what factors may have contributed to infection transmission at Facility A, we reviewed intervals between specimen collection and reported result; median intervals were 1 day (range = 0-4 days) and 3 days (range = 0-7 days), respectively, indicating influenza test results for a patient were followed several days later by SARS-CoV-2 test results for the same patient. Residents were moved into designated zones for the following reasons: 1) after symptom onset but before return of test results, 2) after receiving a positive influenza test result, 3) after receiving a positive SARS-CoV-2 test result, or 4) after exposure to a resident who tested positive. Overall, 85 room changes occurred March 26-May 2. We found that asymptomatic persons who had not been tested, or were found to be without infections, were at times cohorted with symptomatic persons, persons with one positive test result, or persons with two positive test results. As a result, 17 (65%) of 26 asymptomatic residents who were roomed with a symptomatic resident later tested positive for influenza A (n=1), SARS-CoV-2 (n=11), or both (n=5) suggesting exposure and inadvertent SARS-CoV-2 transmission due to cohorting practices. The number of room changes for residents with positive tests results ranged from 0 to 4, underscoring the inconsistent cohorting strategies used as the outbreak unfolded.

We evaluated use of personal protective equipment (PPE) at Facility A; because of a PPE shortages, extended use/reuse of PPE (including gowns, coveralls, face shields, face masks, and respirators,) was practiced by staff when attending to cohorted residents. Because of staffing shortages, limited rooms were in use; some rooms were filled to maximum capacity while others remained unused. But because patients with similar symptoms or with discordant test results were cohorted together, the same PPE was used when care was provided for all patients in a specific cohort. 

About one month later, we were notified of eight asymptomatic Facility A residents who tested positive for influenza A; they were tested after exposure to a resident with respiratory symptoms, but that resident tested negative for influenza. Seemingly persistent influenza transmission during continued low influenza activity, particularly among asymptomatic persons, raised alarms for investigators. A total of 34 swabs collected since April from Facility A residents who tested positive for influenza A at least once had been stored properly and not yet discarded.

They were gathered and re-tested using by RT-PCR; all 34 swabs tested negative for influenza. A c c e p t e d M a n u s c r i p t

We describe an investigation of a suspected mixed outbreak involving influenza and SARS-CoV-2 where inconsistent cohorting and infection control practices along with a nonspecific laboratory test are believed to have contributed to SARS-CoV-2 transmission. Although influenza was deemed not to be the offending respiratory pathogen, the events that unfolded when a mixed outbreak was suspected provide multiple lessons applicable to other LTCFs.

First, Facility A residents were tested for influenza when influenza activity in the community was low and using an assay with low specificity. While LTCFs should consider testing for influenza (or other respiratory pathogens) outside of typical influenza seasons, clinicians should be familiar with the local influenza epidemiology and understand how that changes the optimal test choice and interpretation of results [6, 7] . If there is little local influenza circulation in the community and results of an antigen detection assay (rapid influenza diagnostic test or immunofluorescence assay) are positive, confirmatory testing with a nucleic acid amplification test (e.g., RT-PCR) should be performed before making cohorting decisions both to confirm the diagnosis and for influenza-typing during the low season [7, 8] .

Second, at Facility A, cohorting residents on the same unit based on symptoms alone likely resulted in inadvertent mixing of infected and uninfected residents. According to CDC recommendations for preventing transmission of SARS-CoV-2 in LTCFs, residents with suspected COVID-19 should be cohorted only after laboratory confirmation of infection [1, 9, 10] . Residents in other LTCFs faced with the dilemma of whether or not to cohort patients before laboratory confirmation, should choose not to move patients during the interval between specimen collection and laboratory report unless a private room is available [1, 9, 10] . In previous years, LTCFs might have performed laboratory confirmation on a subset of residents within a respiratory illness cluster; however currently all residents with symptoms consistent with COVID-19 should be tested for SARS-CoV-2 [8, 11] . If influenza and SARS-CoV-2 viruses are A c c e p t e d M a n u s c r i p t co-circulating in the community or facility, residents with consistent symptoms should be tested for both pathogens [10] . If negative for both pathogens, testing should be considered for other viral or bacterial causes of acute respiratory illness [10] .

Third, Facility A experienced PPE shortages, a common problem during the ongoing SARS-CoV-2 pandemic. CDC guidance recommends that decisions about wearing the same PPE for multiple residents should be made only after laboratory testing confirms common respiratory infection [9] . Although not evaluated as part of this investigation, PPE preservation practices could result in exposure to discordant pathogens other than SARS-CoV-2 and influenza; multidrug-resistant bacterial and fungal pathogens and Clostridium difficile are among the pathogens that could be transmitted by direct or indirect contact when the same PPE is used to care for multiple patients. If a LTCF is faced with a high proportion of residents with COVID-19 and safe cohorting strategies are therefore impossible (e.g., the majority of residents are already infected), facilities should consult with public health authorities for guidance [10] .

Management options include transferring residents or keeping residents in their rooms with use of transmission-based precautions for their care or physical barriers between beds in shared rooms to minimize pathogen spread related to frequent or complicated room movements [10] .

CDC guidance on testing and best infection prevention and control practices exist for the situations faced by Facility A [9] . Following these recommendations may prevent inadvertent morbidity and mortality, including those described in this report.

Strategies to Prepare for COVID-19 in Long-term Care Facilities (LTCFs)

COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients

Infection Prevention and Control Assessment Tool for Nursing Homes Preparing for COVID-19

Algorithm to assist in the interpretation of influenza testing results and clinical decision-making during periods when influenza viruses are NOT circulating in the community

Testing and Management Considerations for Nursing Home Residents with Acute Respiratory Illness Symptoms when SARS-CoV-2 and Influenza Viruses are Co-circulating

Interim Guidance for Influenza Outbreak Management in Long-Term Care and Post-Acute Care Facilities

Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes & Long-Term Care Facilities

Testing and Management Considerations for Nursing Home Residents with Acute Respiratory Illness Symptoms when SARS-CoV-2 and Influenza Viruses are Co-circulating

Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t